作者: S. Arie
DOI: 10.1136/BMJ.F6066
关键词: Medicine 、 MEDLINE 、 Conflict of interest 、 Law 、 General partnership 、 Criticism 、 Form of the Good 、 Transparency (behavior) 、 Publishing 、 Alternative medicine
摘要: An attempt to bring closer collaboration between doctors and the drug industry has had be abandoned because of unbridgeable differences two sides. The Ethical Standards in Health Life Sciences Group (ESHLSG), a high profile at partnership medical royal colleges, leading bodies, academics, BMA, NHS Confederation, told BMJ it is disbanding. The decision came after criticism group for publishing guidance on healthcare professionals clinical trial transparency that included several statements were pro-industry not considered based evidence.1 The author campaigner Ben Goldacre condemned “the great good” world having endorsed guidelines, saying they given false reassurance patients some most important problems facing medicine today. However, Tim Evans Royal College Physicians said been useful. “The reached time when needs change evolve into something …